LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 85

Search options

  1. Article: COVID-19 and Diabetes.

    Bellido, Virginia / Pérez, Antonio

    Journal of clinical medicine

    2021  Volume 10, Issue 22

    Abstract: Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on ... ...

    Abstract Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.
    Language English
    Publishing date 2021-11-16
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10225341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital.

    Bellido, Virginia / Freckman, Guido / Pérez, Antonio / Galindo, Rodolfo J

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

    2023  Volume 29, Issue 11, Page(s) 919–927

    Abstract: For years, the standard of care for monitoring dysglycemia in hospitalized patients was capillary blood glucose (CBG) testing with point-of-care glucose meters. Recently, there has been a revolution in novel factory-calibrated continuous glucose ... ...

    Abstract For years, the standard of care for monitoring dysglycemia in hospitalized patients was capillary blood glucose (CBG) testing with point-of-care glucose meters. Recently, there has been a revolution in novel factory-calibrated continuous glucose monitoring (CGM) systems. Newer CGMs are smaller and less expensive, have improved accuracy and longer wear time, and do not require fingerstick CBG for calibration, resulting in increased utilization in ambulatory settings. Consequently, hospitals have noticed increased usability of CGMs among hospitalized patients and expect a progressive continued increase. During the COVID-19 pandemic, there was a critical need for innovative approaches to glycemic monitoring, with several pilot implementation projects using CGM in the intensive care unit and non-intensive care unit settings, further boosting the evidence in this area. Hence, recent guidelines have provided recommendations for the use of CGM in specific hospital scenarios and highlighted the potential of CGM to overcome CBG limitations for glucose monitoring in the inpatient setting. In this review, we provide the following: 1) an up-to-date review of the accuracy of the newer CGMs in hospitalized patients, 2) a discussion of standards for CGM accuracy metrics, 3) a contemporary overview of potential interferences that may cause inaccuracies or poor CGM performance, and 4) required steps for full regulatory approval of CGMs in the hospital and future research steps to advance the field forward.
    MeSH term(s) Humans ; Blood Glucose ; Blood Glucose Self-Monitoring/methods ; Pandemics ; Hospitals ; Glucose
    Chemical Substances Blood Glucose ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2023-06-25
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1473503-9
    ISSN 1530-891X
    ISSN 1530-891X
    DOI 10.1016/j.eprac.2023.06.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Consequences of COVID-19 on people with diabetes.

    Bellido, Virginia / Pérez, Antonio

    Endocrinologia, diabetes y nutricion

    2020  Volume 67, Issue 6, Page(s) 355–356

    Title translation Consecuencias de la COVID-19 sobre las personas con diabetes.
    MeSH term(s) Antimalarials/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Diabetes Complications/complications ; Diabetes Complications/drug therapy ; Health Services Accessibility ; Hospitalization ; Humans ; Hydroxychloroquine/therapeutic use ; Hyperglycemia/complications ; Hyperglycemia/drug therapy ; Hypoglycemic Agents/therapeutic use ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Prognosis ; Risk ; SARS-CoV-2
    Chemical Substances Antimalarials ; Hypoglycemic Agents ; Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language Spanish
    Publishing date 2020-05-11
    Publishing country Spain
    Document type Journal Article
    ISSN 2530-0180
    ISSN (online) 2530-0180
    DOI 10.1016/j.endinu.2020.04.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Inpatient Hyperglycemia Management and COVID-19.

    Bellido, Virginia / Pérez, Antonio

    Diabetes therapy : research, treatment and education of diabetes and related disorders

    2020  Volume 12, Issue 1, Page(s) 121–132

    Abstract: Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been associated with worse outcomes, so it is mandatory to implement effective glycemic ... ...

    Abstract Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been associated with worse outcomes, so it is mandatory to implement effective glycemic control treatment approaches for inpatients with COVID-19. The shortage of personal protective equipment, the need to prevent staff exposure, or the fact that many of the healthcare professionals might be relatively unfamiliar with the management of hyperglycemia may lead to worse glycemic control and, consequently, a worse prognosis. In order to reduce these barriers, we intend to adapt established recommendations to manage hyperglycemia during this pandemic in critical and noncritical care settings.
    Language English
    Publishing date 2020-12-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2566702-6
    ISSN 1869-6961 ; 1869-6953
    ISSN (online) 1869-6961
    ISSN 1869-6953
    DOI 10.1007/s13300-020-00966-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID-19 and Diabetes

    Virginia Bellido / Antonio Pérez

    Journal of Clinical Medicine, Vol 10, Iss 5341, p

    2021  Volume 5341

    Abstract: Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on ... ...

    Abstract Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate. The fact that patients with COVID-19 are usually cared for by health professionals with limited experience in the management of diabetes and the need to prevent exposure to the virus may also be obstacles to glycemic control in patients with COVID-19. Effective clinical care should consider various aspects, including screening for the disease in at-risk persons, education, and monitoring of control and complications. We examine the effect of COVID-19 on DM in terms of glycemic control and the restrictions arising from the pandemic and assess management of diabetes and drug therapy in various scenarios, taking into account factors such as physical exercise, diet, blood glucose monitoring, and pharmacological treatment. Specific attention is given to patients who have been admitted to hospital and critically ill patients. Finally, we consider the role of telemedicine in the management of DM patients with COVID-19 during the pandemic and in the future.
    Keywords diabetes mellitus ; COVID-19 ; hyperglycemia ; glycemic control ; blood glucose monitoring ; telemedicine ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-11-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Consecuencias de la COVID-19 sobre las personas con diabetes

    Bellido, Virginia / Pérez Pérez, Antonio

    2020  

    Keywords covid19
    Language English
    Publishing country es
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Consecuencias de la COVID-19 sobre las personas con diabetes

    Bellido, Virginia / Pérez, Antonio

    Endocrinología, Diabetes y Nutrición

    2020  Volume 67, Issue 6, Page(s) 355–356

    Keywords covid19
    Language Spanish
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2887277-0
    ISSN 2530-0172 ; 2530-0164
    ISSN (online) 2530-0172
    ISSN 2530-0164
    DOI 10.1016/j.endinu.2020.04.001
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Consequences of COVID-19 on people with diabetes

    Bellido, Virginia / Pérez, Antonio

    Endocrinología, Diabetes y Nutrición (English ed.)

    2020  Volume 67, Issue 6, Page(s) 355–356

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2530-0180
    DOI 10.1016/j.endien.2020.04.008
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Consecuencias de la COVID-19 sobre las personas con diabetes./ Consecuencias de la COVID-19 sobre las personas con diabetes./ Consequences of COVID-19 on people with diabetes

    Bellido, Virginia / Pérez, Antonio

    Endocrinol Diabetes Nutr

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32475769
    Database COVID19

    Kategorien

To top